Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Pituitary Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neurofibromatosis 1 1Neurofibroma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Meningioma 1Medulloblastoma 1Glioma, Subependymal 1Glioma 1Germinoma 1Esthesioneuroblastoma, Olfactory 1Ependymoma 1Craniopharyngioma 1Chordoma 1Brain Neoplasms 1Astrocytoma 1Adenocarcinoma, Follicular 1

Interventions

mirdametinib 2tipifarnib 1talimogene laherparepvec 1peginterferon alfa-2b 1nilotinib 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1Vincristine 1Temozolomide 1Talaporfin 1Sirolimus 1Restraint, Physical 1Ranibizumab 1Radiosurgery 1Photochemotherapy 1Neurofibromin 1 1Mn-PyC3A 1Imatinib Mesylate 1Everolimus 1Elasticity Imaging Techniques 1Deoxycholic Acid 1Cryotherapy 1Celecoxib 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibroma × Photochemotherapy × CNS × Clear all
NCT02728388 2025-05-08

Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

Medical College of Wisconsin

Phase 2 Recruiting
30 enrolled
CNS

Neurofibroma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡